Archive for April, 2019

$VVCIF Posts Q4 and 2018 Annual Financial, Operational Results

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), a leading provider of premium cannabis products and services for the medical and adult-use markets and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited, Abcann Medicinals Inc. and Harvest Medicine Inc., this morning announced the release of its Q4 and 2018 annual financial and operating results. “The VIVO team achieved significant milestones in 2018, leading to substantial increases in net revenue, cash position, production capacity, organizational effectiveness and customer development,” VIVO CEO Barry Fishman said in the news release. “The strategic acquisitions of Canna Farms and Harvest Medicine were important drivers of our improved financial results. Through the acquisition of Canna Farms, we have added an award-winning BC craft brand, are leveraging best practices, and have dramatically increased capacity. Harvest Medicine provides a scalable network of medical cannabis clinics offering industry-leading patient care and access to critical data to shape our innovative product development efforts. VIVO remains committed to changing the way people view cannabis and to ensuring medical patients and adult-use consumers have access to our premium cannabis products and services.”

To view the full press release, visit: http://nnw.fm/uE7t7

About VIVO Cannabis(TM)

VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://nnw.fm/VVCIF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Tuesday, April 30th, 2019 Uncategorized Comments Off on $VVCIF Posts Q4 and 2018 Annual Financial, Operational Results

$TCAN Applies For Mfg., Distribution & Transportation Licenses at Adelanto Facility

Vancouver, British Columbia–(April 30, 2019) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) applied for a permanent manufacturing, distribution and a transportation license this week with the city of Adelanto, CA.

“Our immediate focus is to be able to have our city and state licenses in place in Adelanto as soon as possible. Subsequent to the GoodFellas acquisition we will be able to prepare and package the Daily Cannabis Brand pre-rolls at the facility and then deliver the products to the dispensaries without the need to bring in a third party,” stated Jim Pakulis, CEO of TransCanna.

“And as previously stated, the Daily Cannabis Brand has trended in percentage of sales increase since it began selling in the summer of 2018, and our goal is to provide not only the Daily Cannabis Brand with the necessary resources to continue and grow, but to use the Adelanto facility as the first TransCanna satellite distribution network facility throughout the state in an effort to provide reliability, consistency and quality to the dispensaries, and just as importantly scale TransCanna’s ecosystem as expeditiously as possible.”

The Company will provide an update later in the week as it relates to the licensing process for its 196,000 square foot facility in Modesto, CA.

For further information, please visit the Company’s website at www.transcanna.com.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

Media Contact
TransCanna@talkshopmedia.com

604-738-2220

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (604) 609-6199

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tuesday, April 30th, 2019 Uncategorized Comments Off on $TCAN Applies For Mfg., Distribution & Transportation Licenses at Adelanto Facility

$TGODF $TGOD Extraction Services Provider Obtains Organic Certification

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced that its Kelowna-based extraction processing services provider, Valens GroWorks Corp., has obtained its organic certification from Pro-Cert Organic Systems Ltd. “TGOD has been committed to organic since day one. Working with service providers who embrace organic as much as we do is paramount. I want to congratulate the team at Valens for obtaining their organic certification,” Brian Athaide, CEO of TGOD, stated in the news release. “We look forward to delivering certified organic oils of the highest standards to our patients and customers.” As per a previous announcement, TGOD will have exclusive access to Valens’ services for certified organic extraction processing for a period of one year.

To view the full press release, visit http://nnw.fm/fc5N0

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Tuesday, April 30th, 2019 Uncategorized Comments Off on $TGODF $TGOD Extraction Services Provider Obtains Organic Certification

$NETE Aptito Collaborates with HP Inc. for SMB Market

Aptito Becomes an HP Channel Partner for Sales and Support of HP POS Solutions

MIAMI, FL, April 30, 2019 — via NEWMEDIAWIRE – Net Element, Inc. (NASDAQ: NETE)(“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), today announces that its Aptito subsidiary has entered into a channel partner agreement with HP Inc. for sales and support of its line of Android-based POS devices.

The Electronic Transaction Association (“ETA”) Payments Trends to Watch report predicts that US merchants will spend nearly $2 billion on frictionless payment solutions such as technology-enabled integrated POS solutions (IPOS) in 2019, underscoring the value that advanced payments solutions provide to merchants and payment service providers. Net Element is poised to benefit as these merchants upgrade their traditional POS systems to user friendly IPOS solutions that inspire customer loyalty and maximize revenue potential.

According to the U.S. Small Business Administration there is an addressable market of an estimated 600,000 small and mid-sized businesses (SMBs) in the United States. Aptito’s goal is to provide its restaurant management software-as-a-service (SaaS) alongside HP’s POS solutions to offer SMBs cutting-edge technology and competitively priced value-added services backed by HP’s global sales and support. In addition, HP’s Android-based IPOS solutions come with a full suite of retail peripherals and accessories that can be used as tools for assisted selling and mobile transactions.

“We are excited to work with HP to deliver our SaaS in their IPOS solutions to our existing and new merchants worldwide,” commented Andrey Krotov, President of Aptito. “Aptito is currently deployed in 16 countries and growing, HP’s global sales and support provide a springboard for continued expansion.”

About Net Element

Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., the Company aims to grow transactional revenue by innovating SME productivity services using various technology solutions and Aptito, our cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 and 2018 Technology Fast 500™. In 2017 we were recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

Forward-Looking Statements

Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict.  Examples of such risks and uncertainties include whether the Company will benefit from any merchants who upgrade their traditional POS systems, whether Aptito will be successful in its restaurant management SaaS initiatives and whether the relationship will result in continued expansion for the Company. Further examples of such risks and uncertainties include but are not limited to (i) Net Element’s ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Net Element’s ability to maintain existing, and secure additional, contracts with users of its payment processing services; (iii) Net Element’s ability to successfully expand in existing markets and enter new markets; (iv) Net Element’s ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Net Element’s business; (viii) changes in government licensing and regulation that may adversely affect Net Element’s business; (ix) the risk that changes in consumer behavior could adversely affect Net Element’s business; (x) Net Element’s ability to protect its intellectual property; (xi) local, industry and general business and economic conditions; and (xii) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Element with the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

 

Contact:
Net Element, Inc.
+1 (786) 923-0502
www.NetElement.com
Media@NetElement.com

Corporate Communications Contact:
NetworkWire (NNW) 
New York, New York 
www.NetworkNewsWire.com
212.418.1217 Office 
Editor@NetworkWire.com
Tuesday, April 30th, 2019 Uncategorized Comments Off on $NETE Aptito Collaborates with HP Inc. for SMB Market

$NUGS Realizes Key Achievements – NetworkNewsBreaks

Los Angeles, California-based cannabis firm Cannabis Strategic Ventures (OTC: NUGS), through its diverse portfolio of subsidiaries, is focused on supporting entrepreneurial growth within the cannabis sector. An article discussing the company reads, “Thus far in 2019, NUGS has filed an application for uplisting to the OTCQB Venture Market; announced that it will partner with a Santa Barbara County cultivation operation that holds about 40 commercial cannabis licenses in Southern California; revealed that it will add a six-acre Northern California site to its holdings after having obtained over 20 licenses for cannabis manufacturing, distribution and cultivation there; and secured an investment of up to $3 million from student-led business Triton Funds subsequent to an upcoming S1 registration statement, which will allow Cannabis Strategic Ventures to accelerate its cultivation business priorities and the expansion of its existing portfolio brands.”

To view the full article, visit: http://nnw.fm/p4Uig

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://nnw.fm/NUGS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, April 29th, 2019 Uncategorized Comments Off on $NUGS Realizes Key Achievements – NetworkNewsBreaks

$LXRP Innovative Technology Improves Delivery of Nicotine, Cannabinoids

Biotechnology company and drug-delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its pioneering-drug delivery platform DehydraTECH(TM), which improves the speed, taste and delivery of bioactive compounds, including nicotine and cannabinoids. A recent article discussing the company reads, “Furthermore, the DehydraTECH drug delivery platform increases bio-absorption by up to 10 times and lessens the time of onset, with effects being felt within 15 to 20 minutes, as compared to 60 to 120 minutes without the platform. In addition, the technology is patent protected for cannabidiol (CBD) and all other nonpsychoactive cannabinoids. Patents are also granted for THC (tetrahydrocannabinol), other psychoactive compounds and NSAIDs (nonsteroidal, anti-inflammatory drugs), as well as nicotine and other molecules. . . . Lexaria Bioscience has partnered with one of the world’s largest tobacco companies to fund the research and development of the DehydraTECH technology for oral nicotine. Through wholly owned subsidiary Lexaria Nicotine LLC, Lexaria is working to propel innovation in oral, reduced-risk nicotine consumer products utilizing DehydraTECH (http://nnw.fm/OmL1K).”

To view the full article, visit: http://nnw.fm/bSL9u

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and out-licenses its disruptive delivery technology, which promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, April 29th, 2019 Uncategorized Comments Off on $LXRP Innovative Technology Improves Delivery of Nicotine, Cannabinoids

$GGBXF Announces Expiration of Former $APHA Acquisiton Offer

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Thursday announced the expiration of its formal offer to acquire all of the issued and outstanding common shares of Aphria Inc. (TSX: APHA) (NYSE: APHA). According to the update, the company will not be taking up any Aphria shares as the offer conditions have not been met. As announced on April 15, 2019, Green Growth Brands and Aphria entered into an agreement to shorten the offer acceptance expiry time from 5:00 PM (Toronto time) on May 9, 2019 to 5:00 PM (Toronto time) on April 25, 2019. The company has determined not to extend the offer expiry date, and all Aphria shares tendered to the offer will be promptly returned to Aphria shareholders.

To view the full press release, visit: http://nnw.fm/4mQLW

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD, led by CEO Peter Horvath and a leadership team of consumer-focused retail experts. The company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily and Meri + Jayne, with a licensing agreement with the Greg Norman Brand. Already boasting the strongest sales per square feet in the cannabis industry, GGB is expanding its presence in Nevada, Massachusetts and Arizona with CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://nnw.fm/GGBXF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, April 26th, 2019 Uncategorized Comments Off on $GGBXF Announces Expiration of Former $APHA Acquisiton Offer

$VVCIF $VIVO Group Plans 2020 Ballot Measure to Legalize Recreational – 420 with CNW

Coalition406, a new group in Montana, is planning to formulate a ballot measure so that residents can decide whether recreational marijuana should be legalized in the state during the 2020 elections.

In recent years, efforts to legalize adult-use marijuana have attracted growing support in the population. This support is buoyed by the increasing number of states that are either in the process or have already legalized recreational marijuana.

A poll conducted in February this year by researchers from the University of Montana found that 51 percent of all voters in the state support recreational cannabis legalization.

Coalition406 strongly believes that once recreational cannabis is legalized, thousands of people will be employed in the industry and the state will collect revenues that can help to fund education, healthcare and infrastructure projects.

Ted Dick, a campaign manager for Coalition406, announced that the group would sponsor a listening tour throughout the state in order to gather views from people regarding the plan to legalize recreational marijuana. “We want to hear from real Montanans,” he added.

Ted Dick isn’t new on the political landscape of Montana. Previously, he worked as the Executive Director of the Democratic Party in Montana. He therefore brings extensive experience in politics to this initiative to see recreational marijuana legalized.

If the initiative is to make its way onto the ballot in November 2020, at least 25,468 signatures of registered voters will have to be collected after the initiate gets the nod to proceed to the step of gathering signatures.

If the University of Montana poll is indicative of people’s current views in the state, Coalition406 will have to do a lot of work to convince more people to support the measure since the opinion poll shows that legalization currently enjoys a slim majority which can be swayed by those opposed to legalization.

Events in other states which have tried to legalize recreational marijuana also show that the objective is often easier to attain through a ballot than through legislative means.

For example, a law legalizing recreational marijuana was almost a foregone conclusion until voting on the bill was postponed after legislative leaders realized that not enough support existed in the New Jersey senate.

Similarly, the state budget was presented in New York State without including recreational marijuana, and that has cast doubt over plans to legalize recreational marijuana there during this legislative session.

Ballot measures therefore appear to be a better approach to take since the people are often ahead of their elected representatives in terms of voicing what they want. For this reason, VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) applaud Coalition406 for taking the initiative to involve voters directly in matters of legalizing recreational cannabis in Montana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Friday, April 26th, 2019 Uncategorized Comments Off on $VVCIF $VIVO Group Plans 2020 Ballot Measure to Legalize Recreational – 420 with CNW

$TGOD $TGODF European Acquisition HemPoland Receives Organic Certification

TORONTO, April 26, 2019 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX: TGOD) (US: TGODF) is pleased to announce that its wholly owned subsidiary, HemPoland, has received organic certification from EKOGWARANCJA PTRE. This organic certification is provided by the Polish Center for Accreditation on authority from the Minister of Agriculture and Rural Development. HemPoland’s facilities, production processes and product offerings are now certified organic.

TGOD’s extraction and formulation of premium high-quality hemp oils from certified organic raw materials within Poland, sets the foundation for novel and proprietary products to be offered throughout Europe and global markets with official PL-EKO-01 EU certificates. TGOD’s newly certified facility expands its global reach for certified organic production.

“We are incredibly excited that HemPoland’s facilities, production and processes have received organic certification within Europe,” stated Brian Athaide, CEO of TGOD. “This is a major point of differentiation that offers consumers a premium experience. We are proud to continue to deliver and execute on our global organic strategy.”

EKOGWARANCJA PTRE is the largest certification body supported by the Polish Ministry of Agriculture and Rural Development, certifying operators whose goods are being produced in accordance with council regulations.

On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future research, development and innovation by the Company, statements about delivery of product, statements about future production and supply, statements about hemp production and product offerings, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

Friday, April 26th, 2019 Uncategorized Comments Off on $TGOD $TGODF European Acquisition HemPoland Receives Organic Certification

$PBIO Record Q4 FY18 Financial Results, Provides Business Update

  • Q4 2018 Total Revenue Increases 37% over Q4 2017, Setting New Record Quarterly High;
  • FY 2018 Total Revenue Increases 10% over FY 2017, Setting New Record Annual High;
  • Initial Revenue Reported from New BioPharma Services and UST Businesses;
  • Balance Sheet Improves with Significant Conversion of Debt to Equity.
  • Investor Conference Call Scheduled for Thursday, April 25, 2019 at 4:30 PM EDT

SOUTH EASTON, MA / April 25, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences and other industries, today announced financial results for the fourth quarter and fiscal year ended December 31, 2018, provided a business update, and offered limited guidance for FY2019.

Financial Results: Q4 2018 vs. Q4 2017

Total revenue for Q4 2018 was $686,558 compared to $502,708 for the same period in 2017, a 37% increase. This increase was primarily due to our double-digit growth in products and services and in grant revenues.

Products and services revenue was $535,860 for the fourth quarter of 2018 compared to $455,767 for the same quarter of 2017, an 18% increase. Sales of instruments increased to $388,356 in Q4 2018 compared to $317,498 in Q4 2017, an increase of 22%. Sales of consumables were $52,935 for 2018 fourth quarter compared to $60,108 for the same period in 2017, a 12% decrease. Grant revenue in Q4 2018 was $150,698 compared to $46,941 in Q4 2016 an increase of 321%.

Operating loss for Q4 2018 was $1,514,730 compared to $1,318,384 for the same period in 2017. This increase in operating loss was primarily due to increases in general and administrative expense.

Loss per common share – basic and diluted – was $(2.93) for Q4 2018 compared to $(2.37) for the same period in 2017.

Financial Results: FY2018 vs. FY2017

Total revenue for FY2018 was $2,457,871 compared to $2,240,498 for FY2017, a 10% increase. This increase was primarily due to our growth in products and services and in grant revenues.

Products and services revenue was $2,200,539 for the year ended December 31, 2018 compared with $2,065,891 for the year ended December 31, 2017, a 7% increase. Sales of instruments decreased to $1,418,731 for FY2018 compared to $1,459,326 for FY2017, a decrease of 3%. Sales of consumables were $235,132 for the year ended December 31, 2018 compared to $260,331 for the same period in 2017, a decrease of $25,199 or 10%. Grant revenue for fiscal year 2018 was $257,332 compared to $174,607 for the 2017 fiscal year, an increase of $82,725 or 48%.

Operating loss for FY2018 was $4,477,083 compared to $4,647,048 for FY2017. This decrease was primarily due to increases in total revenue.

Loss per common share – basic and diluted – was $(15.33) for FY2018 and $(9.62) for the 2017 fiscal year.

Operational & Technical Highlights: FY2018

  • Bradford A. Young, Ph.D., MBA Joins PBI as Senior VP and Chief Commercial Officer in November 2018.
  • We Converted $13.6 Million of Debt into Equity, Significantly Reducing Total Liabilities.
  • A Major Cancer Research Center Reported that Our Patented Pressure Cycling Technology (“PCT”) Platform Could Play Major Role in Improving Cancer Diagnosis and Treatment.
  • PBI and ISS, Inc. Announced Two-Year Worldwide Co-Marketing and Distribution Agreement.
  • We were Awarded a Key U.S. Patent for Novel High-Pressure Flow-Through Microfluidic Sample Prep Device.
  • Our Ultra High-Pressure Instruments, Processing Methods, and Platform Technologies were Prominently Featured at a Leading, Worldwide Food Science Meeting.
  • We Announced the First Contract Utilizing our Recently Acquired, Patented Protein Refolding and Disaggregation Platform Technology from our December 2017 Purchase of All Assets of BaroFold, Inc.
  • We Accelerated the Development of our Novel Ultra Shear Technology™ (“UST™”) Platform to Pursue Commercialization into Major New Markets, Including Food & Beverages, Nutraceuticals, and Cosmetics.
  • Our Patented UST Platform was Featured as a Potential Breakthrough Processing Method for Higher Quality, Longer Lasting Liquid Foods and Beverages not requiring Refrigeration or Chemical Additives, such as Shelf Stable Milk and Other Dairy Products.
  • We Announced a Strategic Collaboration with Ohio State’s College of Food, Agriculture, and Environmental Sciences, and were Awarded $318,000 from a USDA Grant to Build the First Prototype UST Instrument.
  • We Achieved Two Major Milestones in the Development of our Proprietary UST Technology Platform, Including the Development of a UST-based Process to Make Nanoemulsions of CBD Plant Oil from Hemp.

Mr. Richard T. Schumacher, President and CEO of PBI, said: “This past year was filled with multiple significant financial, operational and technological accomplishments. Key among these was the hiring of Dr. Brad Young as PBI’s Chief Commercial Officer. In this leadership role, Dr. Young will be responsible for assessing multiple major new and divergent market opportunities, and for optimizing the commercialization priorities and strategy for PBI. In addition to this essential role in strategic planning, Dr. Young will also drive the execution of critical partnering and commercialization programs to build customer adoption and accelerate growth.”

Dr. Bradford A. Young, Chief Commercial Officer of PBI, commented: “We are pleased with the overall performance of the Company in 2018, especially in Q4 when total revenue reached a record, all-time high for quarterly revenue. In addition to recording significantly increased sales of our core, PCT platform in 2018, we also recorded the first revenue from our newly launched BioPharma Services business. Our BioPharma Services business helps us not only monetize the BaroFold assets we acquired in December 2017 for improved manufacturing of protein therapeutics, but also supports sales of our Barocycler PCT platform. In fact, we use the Barocycler 2320 EXTREME to perform our BioPharma Services and saw increased demand for our Barocycler 2320 EXTREME in 2018 for quality control applications used during the manufacturing of protein therapeutics.”

Dr. Young continued: “It’s clear that our PCT and BaroFold platform technologies can help companies produce new and improved therapeutic products, a market that is expected to reach $240 billion dollars by 2023 (ResearchAndMarkets.com, 2018). In addition, the new, cutting-edge Ultra Shear Technology (UST) platform we are developing for the production of high-quality nanoemulsion mixtures of oil & water can provide an enhanced way to deliver therapeutics or drugs. Thus, our UST platform has the potential to provide a superior method to develop and deliver drug formulations with improved bio-absorption and faster uptake. We look forward to building on the great progress we’ve made in 2018 and growing the adoption of our life sciences platform technologies for research, development and manufacturing applications in 2019 and beyond.”

Earnings Call

The Company will hold an Earnings Conference Call at 4:30 PM EDT on Thursday, April 25, 2019. To attend this teleconference via telephone, Dial-in: (844) 602-0380 (North America), (862) 298-0970 (International). Verbal Passcode: PBIO Fourth Quarter and Fiscal Year 2018 Financial Call. Replay Number (877) 481-4010; (919) 882-2331 (International). Replay Passcode: 47337. Teleconference Replay Available for 30 days.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired protein disaggregation and refolding technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology™ (“UST™”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Forward Looking Statements

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. The Company’s financial results for the year ended December 31, 2018 may not necessarily be indicative of future results. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBI and this press release, please click on the following website link:
http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.

Investor Contacts:

Richard T. Schumacher, President and CEO
(508) 230-1828 (T)
Bradford A. Young, Ph.D., MBA, SVP and CCO
(508) 230-1829 (F)

 

PRESSURE BIOSCIENCES, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS

 

For the Three Months Ended
For the Year Ended
December 31,
December 31,
2018
2017
2018
2017
Revenue:
Products, services, other
$
535,860
$
455,767
$
2,200,539
$
2,065,891
Grant revenue
150,698
46,941
257,332
174,607
Total revenue
686,558
502,708
2,457,871
2,240,498
Costs and expenses:
Cost of products and services
451,115
421,315
1,280,270
1,273,354
Research and development
297,298
244,032
1,208,160
988,597
Selling and marketing
286,872
394,538
1,009,568
1,209,334
General and administrative
1,166,003
761,207
3,436,956
3,416,261
Total operating costs and expenses
2,201,288
1,821,092
6,934,954
6,887,546
Operating loss
(1,514,730
)
(1,318,384
)
(4,477,083
)
(4,647,048
)
Other (expense) income:
Interest expense, net
(1,152,618
)
(1,623,470
)
(4,168,214
)
(6,055,420
)
Other expense
(211,726
)
(4,635
)
(15,135
)
(5,674
)
Impairment loss on investment
(6,069
)
Gain on extinguishment of embedded derivative liabilities
(74,678)
94,590
260,454
185,452
Incentive shares and warrants
(424,024)
(1,299,340
)
(186,802
Change in fair value of derivative liabilities
Total other (expense) income
(1,863,046
)
(1,533,515)
(5,222,235
)
(6,068,513
Net (loss) income
(3,377,776
)
(2,851,899)
(9,699,318
)
(10,715,561
)
Deemed dividend on down round feature
(213,012)
Deemed dividend on beneficial conversion feature
(1,203,328)
(12,881,899)
Preferred stock dividends
(305,603)
(678,921)
Net (loss) attributable to common shareholders
$
(4,886,707)
$
(2,851,899)
$
(23,473,150)
$
(10,715,561)
Net (loss) per common share – basic and diluted
$
(2.93
)
$
(2.37
)
$
(15.33
)
$
(9.62
)
Weighted average common stock shares outstanding used in the basic and diluted net (loss) income per share calculation
1,666,591
1,202,817
1,530,989
1,114,225

 

PRESSURE BIOSCIENCES, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS

 

December 31, 2018
December 31, 2017
ASSETS
CURRENT ASSETS
Cash and cash equivalents
$
103,118
$
81,033
Accounts receivable, net of $0 reserve at December 31, 2018 and December 31, 2017
474,830
206,848
Inventories, net of $273,547 reserve at December 31, 2018 and $179,600 December 31, 2017
765,478
857,662
Prepaid income taxes
7,482
Prepaid expenses and other current assets
170,734
214,676
Total current assets
1,514,160
1,367,701
Investment in equity securities
16,643
19,825
Property and equipment, net
69,272
22,662
Right of use asset leases
136,385
Intangible assets, net
663,462
750,000
TOTAL ASSETS
$
2,399,922
$
2,160,188
LIABILITIES AND STOCKHOLDERS’ DEFICIT
CURRENT LIABILITIES
Accounts payable
$
658,856
$
589,263
Accrued employee compensation
456,932
368,700
Accrued professional fees and other
1,112,995
800,620
Other current liabilities
1,233,323
1,536,507
Deferred revenue
20,623
263,106
Revolving note payable, net of unamortized debt discounts of $0 and $637,030, respectively
3,500,000
Related party convertible debt, net of unamortized debt discounts of $0 and $31,372, respectively
259,762
Convertible debt, net of unamortized discounts of $156,180 and $401,856, respectively
4,000,805
8,028,014
Other debt, net of unamortized discounts of $9,118 and $48,194, respectively
852,315
1,379,863
Other related party debt
15,000
Total current liabilities
8,350,851
16,725,835
LONG TERM LIABILITIES
Right of use asset liability
136,385
Deferred revenue
37,757
57,149
TOTAL LIABILITIES
8,524,993
16,782,984
COMMITMENTS AND CONTINGENCIES (Note 7)
STOCKHOLDERS’ DEFICIT
Series D Convertible Preferred Stock, $.01 par value; 850 shares authorized; 300 shares issued and outstanding on December 31, 2018 and 2017, respectively (Liquidation value of $300,000)
3
3
Series G Convertible Preferred Stock, $.01 par value; 240,000 shares authorized; 80,570 shares issued and outstanding on December 31, 2018 and 2017, respectively
806
806
Series H Convertible Preferred Stock, $.01 par value; 10,000 shares authorized; 10,000 shares issued and outstanding on December 31, 2018 and 2017, respectively
100
100
Series H2 Convertible Preferred Stock, $.01 par value; 21 shares authorized; 21 shares issued and outstanding on December 31, 2018 and 2017, respectively
Series J Convertible Preferred Stock, $.01 par value; 6,250 shares authorized; 3,458 shares issued and outstanding on December 31, 2018 and 2017, respectively
35
35
Series K Convertible Preferred Stock, $.01 par value; 15,000 shares authorized; 6,880 shares issued and outstanding on December 31, 2018 and 2017, respectively
68
68
Series AA Convertible Preferred Stock, $.01 par value; 10,000 shares authorized; 6,499 and 0 shares issued and outstanding on December 31, 2018 and 2017, respectively
65
Common stock, $.01 par value; 100,000,000 shares authorized; and 1,684,182 and 1,342,858 shares issued and outstanding on December 31, 2018 and 2017 respectively
16,842
13,429
Warrants to acquire common stock
19,807,247
9,878,513
Additional paid-in capital
39,777,301
30,833,549
Accumulated other comprehensive loss
Accumulated deficit
(65,727,538
)
(55,349,299
)
Total stockholders’ deficit
(6,125,071
)
(14,622,796
)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
$
2,399,922
$
2,160,188
Thursday, April 25th, 2019 Uncategorized Comments Off on $PBIO Record Q4 FY18 Financial Results, Provides Business Update

$VVCIF Municipal Approval for B.C. Facility Expansion

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced receipt of local municipal approval for its wholly-owned subsidiary, Canna Farms Limited, for its phase 5 expansion that will add to its Hope, B.C. facility an incremental 2,500 kilograms of indoor capacity. According to the update, the expansion, originally slated to begin construction in 2020, is now, pending regulatory approval, expected to be completed in late 2019 or early 2020. The expansion, with expected capital costs of $3.5 million, consists of 10,000 square feet of cultivation space and is expected to bring VIVO’s total internal production capacity to 13,500 kilograms by early 2020. “Canna Farms is a cultivator and purveyor of premium quality, award winning, small-batch craft cannabis with widespread recognition and appeal as evidenced by its award for ‘Top Reviewed Licensed Producer of the Year’ at the 2018 Canadian Cannabis Awards,” VIVO CEO Barry Fishman said in the news release. “This expansion will further increase Canna Farms’ production capacity to help meet the significant market demand for premium B.C. dry bud. This project represents a strategic deployment of a minor portion of our strong cash position as the Company continues to invest to drive future growth.”

To view the full press release, visit: http://nnw.fm/Azch8

About VIVO Cannabis(TM)

VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://nnw.fm/VVCIF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, April 25th, 2019 Uncategorized Comments Off on $VVCIF Municipal Approval for B.C. Facility Expansion

$LXRP Expands Advisory Board

KELOWNA, BC / April 25, 2019 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, is pleased to announce new appointments to its Scientific Advisory Board, each of whom will contribute advice and recommendations and support related to the Company’s scientific research and product development. Lexaria is honored to have the opportunity of working with each of them.

Dr. Dwayne Godwin is Dean of the Graduate School and Professor in the Departments of Neurobiology and Anatomy and the Institute for Regenerative Medicine at Wake Forest University. He is a neuroscientist with extensive experience in studies of synaptic pharmacology of the brain and translational interests in the physiological basis and neuroimaging of brain injury, alcohol abuse, epilepsy and seizure, Alzheimer’s and PTSD. Dr. Godwin also has experience creating, developing and administering programs at the interface between science, technology, and business, and experience consulting with the pharmaceutical industry on preclinical drug development. He earned his PhD in Behavioural Neuroscience from the University of Alabama, and completed a Postdoctoral Fellowship at the State University of New York – Stony Brook.

Dr. Terry D. Blumenthal is Professor, Psychology and Neuroscience, at Wake Forest University, and is past president of the Society for Psychophysiological Research. His research interests include psychophysiology, research design and methodology, PTSD, information processing, schizophrenia, and developmental neuroscience. Dr. Blumenthal has over 115 publications and has delivered over 200 formal presentations at prestigious events held around the world. He earned both his PhD and MS degrees in Psychology from the University of Florida, and his BSc from the University of Alberta.

Dr. Matthew Fraser is Associate Professor and Director of Basic Science Research in the Department of Surgery, Division of Urology, at Duke University Medical Center. Dr. Fraser has extensive experience in urological and gastrointestinal neuroscience preclinical research, development of research models and methods, experimental design, and early clinical development in both academic and industry settings. He earned his PhD in Physiology/Neuroscience from the University of Pittsburgh School of Medicine.

Dr. Carla Lema Tome is an industry consultant an Adjunct Assistant Professor of Neurobiology and Anatomy at Wake Forest University School of Medicine. She is widely published on topics including but not limited to cellular and molecular neuroscience, inflammation, neurodegeneration, and cancer biology. She has extensive experience in global medical and commercial strategy consulting with emphasis on integrated clinical development, asset and portfolio strategy, launch planning payer research and payer value communications. Her work supporting bioscience projects with high market potential includes the development of forecast and valuation models, conducting strategic analyses of the competitive and market access environment, and developing integrated plans and innovative strategies to maximize asset value. Dr. Lema Tome earned her PhD in Neurobiology and Anatomy and her MBA from Wake Forest University. She also earned an MS in Biological Sciences, Marine Biology, from the Florida Institute of Technology.

“Lexaria Bioscience Corp. is very pleased to welcome these accomplished experts to our Advisory Board, who can provide critical scientific guidance to Lexaria’s ongoing and future R&D programs,” said Chris Bunka, Chief Executive Officer of Lexaria Bioscience Corp. “Lexaria is building towards becoming one of the world’s leaders in drug delivery technology and our most recent Advisors can assist in achieving that goal.”

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH™ delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

www.lexariabioscience.com

For regular updates, connect with Lexaria on Twitter https://twitter.com/lexariacorp and on Facebook https://www.facebook.com/lexariabioscience/

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.
Alex Blanchard, Communications Manager
(250)765-6424 Ext 202

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

Thursday, April 25th, 2019 Uncategorized Comments Off on $LXRP Expands Advisory Board

$NUGS Plants 20,000 at New 6-Acre Licensed Cannabis Site

LOS ANGELES, April 25, 2019  — via NetworkWire — Los Angeles based Cannabis Strategic Ventures Inc. (OTC: NUGS) today announces a major addition to its corporate portfolio through the launch of a six-acre cannabis cultivation site expected to produce a minimum of 30,000 pounds of cannabis per harvest, with an anticipation of four to five harvests per year.

The site, which has been named NUGS Farm North, is located in Northern California. NUGS Farm North is primarily a cultivation operation but will also host manufacturing and distribution business units for Cannabis Strategic Ventures. In total, the site holds 24 cultivation, manufacturing and distribution licenses issued by the Bureau of Cannabis Control in the State of California. NUGS Farm North is expected to operate at maximum capacity by late summer of 2019.

“This is a significant event for Cannabis Strategic and its investors,” commented Simon Yu, CEO Cannabis Strategic Ventures. “NUGS Farm North has planted over 20,000 marijuana clones this week and will plant 10,000 more next week. Beyond the initiation of this first phase of NUGS farm North, we anticipate further expansion towards maximum capacity, which will increase top line revenue.”

Cannabis industry figures show that cannabis plants yield more than one pound of cannabis per harvest. In California, the wholesale price for cannabis opened 2018 at $1,455 per pound and closed the year at $1,196 per pound, averaging $1,197 per pound for the year, according to Cannabis Benchmarks.

The Company has retained a highly skilled team to operate NUGS Farm North consisting of experts with over a dozen years of full lifecycle cannabis operations, as well as research scientists with vast scientific, medical and laboratory backgrounds unique to cannabis operations.

“NUGS Farm North is in a prime location. We have assembled a great team to operate the site and to market and distribute its outputs.  We have already begun cultivation and believe the marketplace is primed for the type of premium cannabis flower we are cultivating.  We look forward to a successful operation at our flagship cultivation site,” added Yu.

About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS. For more information, visit www.CannabisStrategic.com

FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.

Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Contact:
Arlene Guzman
1-310-359-6860 Office
IR@CannabisStrategic.com
www.CannabisStrategic.com

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

Thursday, April 25th, 2019 Uncategorized Comments Off on $NUGS Plants 20,000 at New 6-Acre Licensed Cannabis Site

$YGYI Subsidiary Secures Notable CBD Supply Contract

Youngevity International (NASDAQ: YGYI), a leading omni-direct lifestyle company, recently announced that its Khrysos Global subsidiary secured a contract to produce 99% pure cannabidiol oil from hemp with no tetrahydrocannabinol (THC). An article discussing the company reads, “The one-year supply and processing agreement is expected to begin with shipments this month and continue in equal amounts through March 2020, amounting to what Khrysos President Dwayne Dundore described as 50 percent of the company’s production capacity utilizing its supercritical CO2 technology (http://nnw.fm/CktQ0). Contracts for the remainder of the company’s production capacity are expected to be executed during ‘the next few months,’ he added. . . . ‘We are excited to reach the revenue stage for the end-to-end processing component of our business model,’ Dundore stated in the news release. ‘Due to customer demand, we are implementing our plan of increasing our end-to-end processing capabilities by 10 times in Q3 of this year, providing estimated annual revenue potential in excess of $220 million at current market prices.’”

To view the full article, visit: http://nnw.fm/dfn0V

About Youngevity International Inc.

Youngevity International Inc. is a multichannel lifestyle company operating in three distinct business segments — a commercial coffee enterprise, a commercial hemp enterprise and an omni-direct selling platform. The company features an international selling network and has assembled a virtual main street of products and services under one corporate entity. YGYI offers products from the six top-selling retail categories, including health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry and innovative services. For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://nnw.fm/YGYI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, April 25th, 2019 Uncategorized Comments Off on $YGYI Subsidiary Secures Notable CBD Supply Contract

$LXRP Beverage License Agreement with California Cannabis Company

Kelowna, British Columbia / April 24, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a definitive 5-year agreement, via its subsidiary Lexaria CanPharm ULC, to provide Lexaria’s patented DehydraTECHTM technology to a private California-based cannabis company for its utilization in certain cannabis-based beverages to be produced and sold in the states of California and Nevada.

Financial terms of the agreement are not being disclosed. The DehydraTECH-enabled beverages are protected under Lexaria’s many existing US-granted patents and may include any combination of ready-to-drink beverages such as non-alcoholic beers, wines and spirits; cold or hot coffee or teas, sports drinks and much more.

Lexaria has developed methods of combining nano-emulsion technology with its proprietary DehydraTECH processes to create beverages with market-leading aesthetic and performance characteristics. Lexaria is currently experiencing unprecedented demand in several North American markets for use of its technology for beverage applications.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),nicotine and other molecules.

www.lexariabioscience.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.

Alex Blanchard, Communications Manager

(250)765-6424 Ext 202

Or

NetworkNewsWire (NNW)

www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

Wednesday, April 24th, 2019 Uncategorized Comments Off on $LXRP Beverage License Agreement with California Cannabis Company

$PBIO to Discuss Q4 FY18 Financials, Business Update, Apr 25

Conference Call Scheduled for Thursday, April 25th at 4:30pm ET

SOUTH EASTON, MA / April 24, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2018 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone or via a link on the Company’s website approximately one day after the teleconference).

The teleconference will include a Company presentation followed by a question & answer period.

Date: Thursday, April 25, 2019 Time: 4:30 PM Eastern Time (ET)

To attend this teleconference, live by telephone:

Dial-in: (844) 602-0380 (North America); (862) 298-0970 (International)

Verbal Passcode (for the operator): PBI Fourth Quarter and FY 2018 Financial Call & Business Update

For those unable to participate in the live teleconference, a replay will be available beginning Friday, April 26, 2019. The replay will be accessible via telephone and the Company’s website for 30 days.

Replay Number: (877) 481-4010 (North America); (919) 882-2331 (Int’l); Replay Passcode: 47337

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

For more information about PBI and this press release, please click on the following link:

http://www.pressurebiosciences.com

Please visit us on Facebook, LinkedIn, and Twitter.

Investor Contacts:

Richard T. Schumacher, President & CEO (T) 508-230-1828
Bradford A. Young, Ph.D., MBA, SVP & CCO (F) 508-230-1829

Wednesday, April 24th, 2019 Uncategorized Comments Off on $PBIO to Discuss Q4 FY18 Financials, Business Update, Apr 25

$NETE Noteworthy Revenue Growth Driven by NA Transaction Solutions

Net Element (NASDAQ: NETE), a global technology and value-added solutions group, recently reported substantial financial growth in 2018. A recent article discussing the company reads, “The company’s revenue over the year went up to $65.8 million, marking an increase of 10 percent on an annual basis. Growth through the company’s North American transaction solutions segment was the primary driver for the strong results, as the company’s management announced in an earnings conference call on April 2, 2019 (http://nnw.fm/sF47f). . . . The North American transaction solutions segment experienced annual growth of 16 percent in 2018. The United States accounted for 90 percent of the overall revenue, while international revenue contributed 10 percent.”

To view the full article, visit: http://nnw.fm/6ScYq

About Net Element Inc.

Net Element (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the United States and selected emerging markets. In the U.S., the company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500. In 2017, Net Element was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://nnw.fm/NETE

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, April 24th, 2019 Uncategorized Comments Off on $NETE Noteworthy Revenue Growth Driven by NA Transaction Solutions

$TCAN Completes Acquisition of Large California Site

  • TransCanna Holdings’ purchase of a 5.5-acre site in Northern California with a 196,000-square-foot facility onsite is expected to set the stage for the company’s self-contained ecosystem to create or acquire 15 premium brands by controlling all aspects of production, distribution and sales
  • Cannabis sales in California are expected to reach $5.1 billion this year and climb to $7.7 billion by 2022
  • TransCanna’s site purchase advances plans for an additional 600,000-square-foot facility for biomass growth
  • A successful, oversubscribed private placement raised gross proceeds of C$16 million to help fund plans for the site

Cannabis branding and distribution company TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) has finalized the acquisition of “arguably the largest vertically integrated cannabis centric” multi‐purpose facility in California, setting the stage for edification of a self-contained cannabis hub operation that includes integrated divisions for transportation and distribution, cultivation and nursery, lab extraction, manufacturing and packaging.

The three-story, 196,000-square-foot facility is part of a larger 5.5-acre property purchase that the company envisions as green space, where up to 600,000 square feet of new …

Read more »

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://nnw.fm/TCAN

 

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, April 24th, 2019 Uncategorized Comments Off on $TCAN Completes Acquisition of Large California Site

$TCAN Will Acquire Daily Cannabis Goods Brand, GoodFellas Acquisition

Vancouver, British Columbia–(April 23, 2019) – TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (“TransCanna” or the “Company”) announces that the acquisition of GoodFellas will result in acquiring an additional existing brand called Daily Cannabis Goods (“Daily”). The Daily brand consists of three quality half gram pre-rolls which are attractively packaged and priced.

“The Daily brand is a perfect fit for TransCanna,” Stated Jim Pakulis, CEO of TransCanna. “The start-up costs were nominal, it has SKU velocity now that it’s selling in over thirty dispensaries, and it’s constantly beating the competition due to consumer demand.”

“The Daily brand has seen a steady consistent increase in sales since it commenced in August 2018. The first month shipments of units exceeded 2,100 and by December the number of units shipped for the month exceed 10,000. We anticipate closing the acquisition of GoodFellas by May 20th, and then we’ll budget accordingly in order to work on increasing units sold.”

Subsequent to the acquisition, TransCanna anticipates expanding the Daily line to include three additional SKU’s.

For further information, please visit the Company’s website at www.transcanna.com.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

Media Contact
TransCanna@talkshopmedia.com
604-738-2220

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (604) 609-6199

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tuesday, April 23rd, 2019 Uncategorized Comments Off on $TCAN Will Acquire Daily Cannabis Goods Brand, GoodFellas Acquisition

$TGOD $TGODF on the Move, Big Deal Behind the Oil Sales License

In a press release earlier today, The Green Organic Dutchman (TSX:TGOD) (OTCQX:TGODF) announced that it has received its oil sales license from Health Canada. The news has spurred on TGOD stock, which, as a result, is up roughly 7% and trading at $4.18 CAD on the TSX.

TGOD Stock: Oil Sales License

The news comes a short time after the company received its oils production license earlier this month.

Upon that news, TGOD installed a “state-of-the-art supercritical CO2 extraction system, capable of processing ultra-pure, environmentally friendly, organic cannabis oils.”

This focus on high-quality certified-organic cannabis is exactly what TGOD is famed for. Its aim to create ultra-premium cannabis products is possible because of the company’s extraction process. This is a unique protocol that results in a cannabis oil “as close to the original plant composition” as possible.

Now, with the sales license in hand, TGOD will embark on the global sale of this high-quality cannabis oil, much to the excitement of TGOD stock investors.

In the press release, TGOD CEO Brian Athaide said the following:

“We are pleased to offer TGOD’s medical patients access to new premium certified organic cannabis oils […] In addition, this step will assist TGOD in transforming our premium quality organic raw material into a variety of higher-margin cannabis products which is core to our business plan, providing us with the opportunity to bring to market innovative and novel products, including beverages and edibles, once regulations permit. Cannabis 2.0 is rapidly approaching, and we will be ready.”

TGOD Stock: Grower’s Circle

In March, The Green Organic Dutchman announced that the sale of its cannabis flower had started. A select group of medical patients called the Growers’ Circle, were given early access to the company’s first-certified organic flower. This initial rollout was a limited offering used to help TGOD perfect distribution and gauge response ahead of the company’s full-scale rollout, which will now include cannabis oils.

Initial feedback from the Grower’s Circle has, according to the company, been extremely positive.

Now, TGOD’s Unite Organic Cannabis Oil will begin shipping later this month.

Tuesday, April 23rd, 2019 Uncategorized Comments Off on $TGOD $TGODF on the Move, Big Deal Behind the Oil Sales License